Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuroscience Methods

• Publication date

  2011-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jneumeth.2010.12.025PMID 21219931PMCID PMC3049315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced levels of human apoE4 protein in an animal model of cognitive impairment.

  2011influential reference
• Alzheimer's disease.

  2011cited by this paper
• Isoform-specific proteolysis of apolipoprotein-E in the brain.

  2011cited by this paper
• A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

  2010cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Proposed mechanism for lipoprotein remodelling in the brain.

  2010cited by this paper
• Amyloid load in nondemented brains correlates with APOE e4.

  2010cited by this paper
• Endocytic pathways mediating oligomeric Aβ42 neurotoxicity

  2010cited by this paper
• Size-dependent neurotoxicity of beta-amyloid oligomers.

  2010cited by this paper
• Accumulation of intraneuronal Aβ correlates with ApoE4 genotype

  2010cited by this paper
• American Society for Neurochemistry

  2010cited by this paper
• Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease

  2010cited by this paper
• GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein.

  2010cited by this paper
• Reelin signaling antagonizes β-amyloid at the synapse

  2009cited by this paper
• Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice

  2009cited by this paper
• The role of apolipoprotein E in Alzheimer's disease.

  2009cited by this paper
• Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease

  2008cited by this paper
• Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.

  2008cited by this paper
• Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice

  2008cited by this paper
• Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits

  2008cited by this paper
• Amyloid &bgr;-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain

  2008cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007influential reference
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007influential reference
• Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.

  2007cited by this paper
• Aβ42 neurotoxicity in primary co-cultures: Effect of apoE isoform and Aβ conformation

  2007cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• The development of amyloid beta protein deposits in the aged brain.

  2006cited by this paper
• Differential Expression of Synaptic Proteins in the Frontal and Temporal Cortex of Elderly Subjects With Mild Cognitive Impairment

  2006cited by this paper
• Amyloid- (cid:1) Peptide Remnants in AN-1792-Immunized Alzheimer’s Disease Patients A Biochemical Analysis

  2006cited by this paper
• Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice*

  2006cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006influential reference
• Premorbid effects of APOE on synaptic proteins in human temporal neocortex.

  2006cited by this paper
• Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1

  2006influential reference
• Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis

  2006cited by this paper
• The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease*

  2005cited by this paper
• Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice

  2004cited by this paper
• Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

  2004cited by this paper
• Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

  2004cited by this paper
• Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

  2004cited by this paper
• Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice.

  2004cited by this paper
• Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.

  2004cited by this paper
• Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease

  2004cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC‐P/collagen type XXV

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease

  2002cited by this paper
• Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease

  2001cited by this paper
• Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?

  2001cited by this paper
• Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease

  2001cited by this paper
• Effect of Apolipoprotein E Allele ε4 on the Initial Phase of Amyloid β-Protein Accumulation in the Human Brain

  2000cited by this paper
• Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

  2000cited by this paper
• Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease.

  1998cited by this paper
• Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis*

  1997cited by this paper
• The Paired t Test Under Artificial Pairing

  1997influential reference
• Quantitation of apolipoprotein E.

  1996cited by this paper
• Is Alzheimer's disease an apolipoprotein E amyloidosis?

  1995cited by this paper
• Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.

  1994cited by this paper
• Purification and tissue level of the beta-amyloid peptide precursor of rat brain.

  1991cited by this paper
• The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2.

  1991cited by this paper
• Transactions of the American Society for Neurochemistry : twenty-first annual meeting : program : March 4-9, 1990, Hyatt Regency Hotel, Phoenix, Arizona

  1990cited by this paper
• The amyloid precursor protein of Alzheimer's disease is released by human platelets.

  1990cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Workshop on apolipoprotein quantification.

  1983cited by this paper
• Molecular Neurodegeneration Apolipoprotein E Levels in Cerebrospinal Fluid and the Effects of Abca1 Polymorphisms

  year unknowncited by this paper

• Fluorescence from dual molecular rotors allows sensitive detection of widespread brain pathology in a mouse model of Alzheimer’s disease

  2026cites this paper
• The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease

  2025cites this paper
• ACLY regulates autolysosome acidification through tubulin acetylation‐mediated assembly of V‐ATPase subunits in Alzheimer's disease model mice

  2025cites this paper
• Increase of brain Aβ peptides and secretase activity during normal aging in rodent and human.

  2025cites this paper
• Microglial cGAS Deletion Preserves Intercellular Communication and Alleviates Amyloid‐β‐Induced Pathogenesis of Alzheimer's Disease

  2025cites this paper
• Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer’s Disease Validated in a Mouse Model Expressing Human APOE3/APOE4

  2024cites this paper
• APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice

  2024cites this paper
• Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy

  2024cites this paper
• Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease

  2023cites this paper
• Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation

  2023cites this paper
• A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease

  2023cites this paper
• β_2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice

  2023cites this paper
• A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3

  2023cites this paper
• Aging-induced YTHDF aggregates impair mitochondrial function by trapping mitochondrial RNAs and suppressing their expression in the brain

  2023cites this paper
• Rescue of Alzheimer’s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells

  2023cites this paper
• Microglial cGAS deletion protects against amyloid-β induced Alzheimer’s disease pathogenesis

  2023cites this paper
• Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease.

  2023cites this paper
• Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model

  2023cites this paper
• A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice

  2023cites this paper
• APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice

  2023cites this paper
• Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

  2022cites this paper
• Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer’s models

  2022cites this paper
• Amyloid futures in the expanding pathology of brain aging and dementia

  2022cites this paper
• APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia

  2021cites this paper
• TMEM59 Haploinsufficiency Ameliorates the Pathology and Cognitive Impairment in the 5xFAD Mouse Model of Alzheimer’s Disease

  2020cites this paper
• A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance

  2020cites this paper
• Astrocyte-derived clusterin suppresses amyloid formation in vivo

  2020cites this paper
• A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models

  2019influential citation
• APOE4-mediated amyloid-&bgr; pathology depends on its neuronal receptor LRP1

  2019cites this paper
• Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

  2019cites this paper
• APOE 4-mediated amyloid-b pathology depends on its neuronal receptor LRP 1

  2019cites this paper
• Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice

  2018influential citation
• Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice

  2018cites this paper
• HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease

  2017cites this paper
• A protocol for quantitative analysis of murine and human amyloid-β1-40 and 1-42.

  2017cites this paper
• EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease[S]

  2017cites this paper
• Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition

  2017influential citation
• NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies

  2016cites this paper
• An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo.

  2016cites this paper
• Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease

  2016cites this paper
• Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.

  2016cites this paper
• bio sen sis MOAB-2 Mouse Monoclonal antibody to Amyloid beta peptide ( A beta 40 / 42 ) , purified

  2015cites this paper
• The Resveratrol Trimer Miyabenol C Inhibits β-Secretase Activity and β-Amyloid Generation

  2015cites this paper
• APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice

  2015cites this paper
• In vitro binding of [3H]PIB to human amyloid deposits of different types

  2014cites this paper
• Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo*

  2014cites this paper
• Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer's disease.

  2014cites this paper
• Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.

  2014cites this paper
• Simultaneous determination of post-translational racemization and isomerization of N-terminal amyloid-β in Alzheimer's brain tissues by covalent chiral derivatized ultraperformance liquid chromatography tandem mass spectrometry.

  2014cites this paper
• APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.

  2014cites this paper
• Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-β Precursor Protein Processing in Alzheimer's Disease Models

  2014cites this paper
• Activity Modulate Retinoid X Receptor Agonist Genotype APOE Pathology and β Amyloid-Molecular Bases of Disease :

  2014cites this paper
• Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

  2014cites this paper
• Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice.

  2013cites this paper
• Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples*♦

  2013influential citation
• Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1

  2013influential citation
• APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease*

  2012influential citation
• TDP-43: a new player on the AD field?

  2012cites this paper
• LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β

  2012influential citation
• Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody

  2012cites this paper
• Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1

  2011cites this paper
• Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex

  2011cites this paper